{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" Let me look at the provided context to find the answer. The context has four entries, all with the title \"Estimating the number of infections and the impact of non-\" and the passage \"Lockdown\" repeated. The last entry has a date: 24/3/2020.\n\nHmm, the context seems a bit incomplete. The titles are cut off, and the passages just say \"Lockdown\" or \"banned Implemented with lockdown.57 24/3/2020\". Maybe the user is referring to a study or report about lockdowns during a pandemic, like COVID-19. The date 24/3/2020 is around when many countries started implementing lockdowns. \n\nSince the context is limited, I need to rely on general knowledge. A lockdown typically refers to strict restrictions on movement and activities to prevent the spread of a disease. It involves closing non-essential businesses, schools, and public spaces, and people are required to stay at home except for essential needs. The context mentions \"non-banned Implemented with lockdown,\" which might mean that certain measures were enforced alongside lockdowns. \n\nBut the user's question is straightforward. They want a definition. Since the provided context doesn't have a detailed explanation, I should answer based on common understanding. I should mention that a lockdown is a public health measure to limit movement and gatherings to control disease spread, often used during pandemics. Also, note that the context references a study from March 2020, which aligns with the early stages of the COVID-19 pandemic when lockdowns were widely implemented.\n</think>\n\nA **lockdown** is a public health measure implemented to restrict movement and gatherings of people in order to slow the spread of a contagious disease, such as during a pandemic. It typically involves closing non-essential businesses, schools, and public spaces, and requiring individuals to stay at home except for essential activities (e.g., medical care, groceries). The context provided references a study from March 24, 2020, which likely examines the impact of lockdowns on reducing infections, a common strategy during the early stages of the COVID-19 pandemic.",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which I know stands for Chikungunya virus. Let me look back at the provided context to find the relevant information.\n\nFirst, in the first passage, there's a list of complications from most common to least common. The passage says: \"Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.\" So that's a list of seven complications. \n\nThen, looking at the second passage, it mentions that neonates who contract CHIKV can develop meningoencephalitis. Wait, meningoencephalitis is already listed in the first passage. But the second part also talks about perinatal transmission leading to high morbidity. However, the specific complications listed in the first passage seem to be the main ones. \n\nI need to make sure I include all the complications mentioned. The first passage lists respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure. The second passage adds that neonates can get meningoencephalitis, but that's already in the list. Also, the second passage mentions \"other complications,\" but the main list is in the first part. \n\nWait, the second passage starts with \"and complications.\" Maybe that's a typo or continuation from another part? The user provided two passages. The first one ends with \"and kidney failure,\" then the second passage starts with \"and complications.\" But the second passage then talks about perinatal transmission and neonates developing meningoencephalitis. So maybe the main list is in the first passage. \n\nSo the answer should list all the complications from the first passage. Let me check again. The first passage says \"Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.\" That's seven complications. \n\nAdditionally, the second passage mentions that neonates can develop meningoencephalitis, but that's already included. So the answer should list all those seven complications",
      "retrieved_chunks": [
        "Passage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis.",
        "Passage: and complications.",
        "Title: Chikungunya: A Potentially Emerging Epidemic?",
        "Title: Chikungunya: A Potentially Emerging Epidemic?"
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.8,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what the answer is here. The user is asking, \"What does Clade A contain?\" based on the provided context. \n\nFirst, I need to look through the given passages and context to find any mention of Clade A. The context talks about different clades like 1B.1, 1B.2, 1A.1, and mentions lineages such as 1C and 1A. However, there's no specific mention of \"Clade A\" in the passages provided. The passages discuss the 1A lineage, which is divided into second-order clades like 1A.1, but the question is about \"Clade A,\" which isn't directly referenced.\n\nThe user might be confusing the numbering here. The context refers to lineages with numbers like 1A, 1B, 1C, etc., but not a standalone \"Clade A.\" The answer should probably clarify that there's no information on Clade A in the provided context. The answer examples given in the context are about 1A.1, 1B.1, etc., which are part of the 1A, 1B lineages. \n\nSince the question is about Clade A specifically, and the provided passages don't mention Clade A, the correct answer would be that there's no information available in the context about Clade A. The user might have made a typo or misread the lineage numbers. The answer should point out that the context discusses lineages like 1A, 1B, 1C, but not a Clade A.\n</think>\n\nThe provided context does not mention a specific \"Clade A.\" Instead, it discusses lineages such as **1A**, **1B**, and **1C**, which are part of a hierarchical nomenclature system for swine influenza A virus H1 hemagglutinin genes. For example:  \n- The **1A lineage** contains 1,889 viruses from 34 countries and is subdivided into second-order clades like **1A.1**.  \n- The **1C lineage** includes 315 viruses from China and South Korea.  \n\nIf the question intended to refer to the **1A lineage**, it contains viruses from 34 countries collected from 2010 onward, further divided into second-order clades (",
      "retrieved_chunks": [
        "For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade.",
        "Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception.",
        "For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting.",
        "Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 .",
        "Title: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1A swine lineage. The 1A lineage contained 1,889 viruses from 34 countries collected from 2010 to the present . According to our nomenclature rules, we refined the classification of 1A viruses into three second-order divisions, each of which corresponds to earlier, regional classifica- Table 2 ."
      ],
      "computed_relevance": 0.16666666666666666,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. I need to look through the provided context to find relevant information.\n\nFirst, the context mentions that the S1 subunit of 2019-nCoV shares around 70% identity with the two bat SARS-like CoVs and human SARS-CoV. The core domain of the RBD (receptor binding domain) is highly conserved. Also, there's a note that most bat SARS-related CoVs have two stretches of deletions in the spike receptor binding domain compared to human SARS-CoV. \n\nThe S2 subunit is mentioned as being highly conserved with 99% identity, but the question is about S1. The other parts talk about structural elements like SL1 to SL8, but those might be more related to the S2 or other regions. \n\nSo the key points are the 70% identity for S1 and the conserved RBD core. The deletions in bat CoVs are in the spike's RBD, but the 2019-nCoV's S1 has a core domain that's conserved. So even though there's lower overall identity (70%), the critical RBD part is maintained. \n\nI should structure the answer to state the 70% identity and mention the conserved RBD core. Also, note that bat SARS-related CoVs have deletions in that area, but 2019-nCoV doesn't, making it more similar to human SARS-CoV in that region. That explains why the RBD is conserved despite lower overall S1 similarity.\n</think>\n\nThe S1 subunit of 2019-nCoV shares approximately **70% identity** with the S1 subunits of bat SARS-like CoVs and human SARS-CoV. However, the **core domain of the receptor binding domain (RBD)** within the S1 subunit is highly conserved across these viruses. Notably, most bat SARS-related CoVs have **two stretches of deletions** in the spike RBD compared to human SARS-CoV, but 2019-nCoV retains a conserved RBD structure similar to human SARS-CoV, suggesting",
      "retrieved_chunks": [
        "Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ).",
        "We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV .",
        "The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b.",
        "These findings provide the basis for\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: As shown in Figure 7 , the SARS-CoV 5 \u2032 -UTR contains SL1, SL2, SL3, SL4, S5, SL5A, SL5B, SL5C, SL6, SL7, and SL8."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" and I need to answer based on the provided context.\n\nFirst, I'll look through the given passages. The context mentions Bacillus subtilis in several places. Let me go through each part step by step.\n\nThe first passage says that Bacillus subtilis helps retain gut barrier integrity, decreases endotoxin concentration, and reduces gut inflammation, citing Bene et al., 2017. So that's a function related to gut health. Then it mentions that B. subtilis produces surfactins, fengycins, and iturins in a specific ratio (6:37:57). These are probably the compounds it secretes, which might be part of its secretome as the title suggests.\n\nThe second passage talks about Bacillus species being used in probiotics like Enterogermina, Biosubtyl, etc. It also mentions that historically, Bacillus was not considered part of the normal intestinal microbiome, unlike Lactobacillus. But they are found in fermented foods and used as probiotics. The third passage starts with \"B.\" but seems incomplete, maybe part of a sentence about Bacillus in the environment.\n\nPutting this together, Bacillus subtilis is a species of Bacillus that's used as a probiotic. It's part of the secretome discussed in the title, which is about how intestinal bacilli act as a natural guard against diseases. The functions include maintaining gut barrier, reducing inflammation, and producing certain compounds. Also, it's used in various probiotic products and traditional fermented foods.\n\nI need to make sure I don't include incorrect information. The key points are: it's a probiotic bacterium, part of the Bacillus genus, produces specific lipopeptides (surfactins, fengycins, iturins), helps with gut health by maintaining barrier function and reducing inflammation, and is used in commercial probiotics and fermented foods. Also, note that while traditionally not considered part of the normal gut microbiome, it's now recognized for its beneficial roles when administered as a probiotic.\n\nI should structure the answer to mention its role as a probiotic, the specific benefits (gut barrier, inflammation), the compounds it produces, and its use in products. Also, maybe mention that it's found in fermented foods and is part of the secretome that",
      "retrieved_chunks": [
        "Bacillus spp.",
        "subtilis also retained gut barrier integrity, decreased the endotoxin concentration and reduced gut inflammation Bene et al., 2017) .",
        "subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 .",
        "subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp.",
        "In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B."
      ],
      "computed_relevance": 0.5,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. First, I need to look through the provided context and passages to find relevant information.\n\nLooking at the first context, it mentions a study that considered five gradations of pandemic severity and various interventions. However, it's about pH1N1 and includes multiple waves or combinations, not specifically single-wave. The passage about the 1889 pandemic talks about three major waves, so that's multiple waves. The 1918 pandemic is mentioned with possible herald waves stretching back to 1915, but again, the main 1918 pandemic had multiple waves. \n\nThe Hong Kong study from 2009 mentions convalescent plasma treatment but doesn't specify wave patterns. The Richards model passage discusses multi-wave epidemics, so that's not helpful here. The economic analysis passage refers to five pandemic severity categories but doesn't mention single-wave specifically.\n\nWait, the user is asking about severe, single-wave pandemics. The provided contexts don't explicitly mention single-wave pandemics. The 1889 pandemic had three waves, and the 1918 had multiple. The 2009 pH1N1 might have had multiple waves too. The studies cited in the contexts mostly deal with multi-wave scenarios or models that account for multiple waves. \n\nIs there any mention of a severe pandemic that was a single wave? The answer might be that there isn't any in the provided texts. The user might be expecting an answer based on the given contexts, so if none of the passages discuss single-wave, then the answer would state that past research hasn't focused on single-wave but rather multi-wave pandemics. Alternatively, maybe the 1892 wave being the most intense in the 1889 pandemic is considered a single wave? But the context says the 1889 pandemic had three waves. \n\nHmm. The answer should be that the provided research doesn't specifically address severe, single-wave pandemics. The studies mentioned deal with multi-wave scenarios or models that include multiple waves. Therefore, past research as per the contexts hasn't focused on single-wave but rather on multi-wave pandemics. The user might need to infer that based on the absence of single-wave mentions.\n</think>\n\nThe provided contexts do not explicitly mention research focused on **severe, single-wave pandemics**.",
      "retrieved_chunks": [
        "The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic.",
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review.",
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies.",
        "Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave.",
        "To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's see. The user is asking how many reported viral pneumonia cases there are based on the provided context. Let me go through each passage carefully.\n\nFirst, the first context is about pneumonia in adults with influenza in the US from 2005-2008. It mentions that patients with pneumonia were more likely to get antiviral therapy, but it doesn't give a specific number of cases. So probably not here.\n\nThe second context is a clinical review about primary influenza viral pneumonia. It talks about bacterial co-infections in the 2009 H1N1 pandemic. They mention 77 fatal cases where 29% had bacterial pneumonia. But the question is about viral pneumonia. Wait, the 77 cases are of pandemic H1N1, which is viral. But the 29% is about bacterial co-infection. So the 77 cases are viral, but the question is about how many viral pneumonia cases. So maybe 77 is a number here? But the question is asking for the total reported, so maybe there's another number.\n\nThird context is another part of the same clinical review. It discusses attack rates during seasonal vs pandemic. For example, in La Gloria, they had 29% and 61% attack rates. But attack rates are about how many people get infected, not necessarily the number of pneumonia cases. So maybe not directly relevant.\n\nFourth context is about the 2019-nCoV (COVID-19) pneumonia. As of January 26, 2020, there were 2744 confirmed cases in China. The passage says \"pneumonia with 2019-nCoV infection,\" so these are cases of viral pneumonia caused by the new coronavirus. The question is asking for reported viral pneumonia cases. So this seems like a direct number. The answer might be 2744. But wait, the user is asking for \"reported viral pneumonia\" in general? Or specifically from the contexts provided?\n\nLooking back at the question: \"How many reported viral pneumonia?\" The answer should be based on the provided contexts. The first three contexts are about influenza-related pneumonia, and the fourth is about COVID-19. The fourth context gives a specific number: 2744 confirmed cases of pneumonia with 2019-nCoV. The other contexts don't give",
      "retrieved_chunks": [
        "Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01].",
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients .",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age .",
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths.",
        "The most common coinfecting bacterial pathogens were pneumococcus, Staphylococcus aureus, and Streptococcus pyogenes, with a median duration of illness of 6 days ."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.875,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, it says, \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. The key terms here are \"high throughput\" and \"deep sequencing methods.\" \n\nI should check the other passages to make sure there's no conflicting information. The second passage talks about single nucleotide differences and specific regions of the genome, but doesn't mention the method used. The third passage mentions whole genome sequencing being used extensively, but that's more about tracking travel and variation. The fourth passage discusses genetic recombination and lineage differences but again doesn't mention the primary method of analysis.\n\nSo the first passage clearly states that high throughput or deep sequencing is the main method. The answer should focus on that. I need to present this in a concise way, making sure to include the terms from the context. Also, the user wants the answer in a box, so I'll format it accordingly.\n</think>\n\nAnswer: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
        "Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable.",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "Continued laboratory testing, sequencing, analysis, timely data sharing and clear communication are essential for such vigilance to be effective.",
        "While human and camel whole genome sequences have retained >99 % identity with each other, members of genetically distinct lineages can and do swap genetic material when suitable conditions and coinfections co-occur ."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.125,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided context to find the relevant information.\n\nFirst, looking at the first passage under the title about influenza A viruses, it mentions that GFP was observable in the lungs of infected mice using IVIS for whole-organ imaging. Also, flow cytometry was used to analyze infection progression in antigen-presenting cells. The imaging of murine lungs showed the infection starting near large airways and spreading deeper. So IVIS and flow cytometry are methods mentioned here.\n\nIn the second passage about bat cell lines, they used an inverted fluorescence microscope to monitor GFP expression after applying an overlay. They also mention immunofluorescence microscopy during passaging with a GFP antibody. Additionally, images were taken with one color channel showing GFP cells in white and others in black.\n\nPutting this together, the tracking methods include IVIS for whole-organ imaging, flow cytometry, inverted fluorescence microscopy, immunofluorescence microscopy, and possibly imaging with specific color channels. The answer should list these techniques as the methods used to track the spread.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using **in vivo imaging** (e.g., IVIS for whole-organ imaging of lungs in mice), **flow cytometry** to analyze infection progression in antigen-presenting cells, **inverted fluorescence microscopy** to monitor GFP expression in cell cultures, and **immunofluorescence microscopy** during passaging. Additionally, **fluorescence imaging with specific color channels** (e.g., GFP-expressing cells in white, non-expressing cells in black) was used to visualize spatial distribution. These methods collectively enabled observation of viral spread from airway regions to deeper lung tissues and in cell culture systems.",
      "retrieved_chunks": [
        "Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs .",
        "For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution.",
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed .",
        "Expression of GFP was monitored during passaging by immunofluorescence microscopy using the GFP antibody.",
        "One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black ."
      ],
      "computed_relevance": 0.42857142857142855,
      "computed_utilization": 0.5714285714285714,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with similar titles and mentions of CT disinfection procedures.\n\nFirst, I need to parse the context. The first passage mentions \"Noncontaminated CT disinfection procedures after suspected COVID-19 case examination.\" The second one is \"Fever-CT disinfection procedures after examination.\" The third part repeats \"fever-CTs) after these sterilization procedures.\" And the fourth says \"equipment and prepares to disinfect the imaging equipment immediately after the examination.\"\n\nPutting this together, the key points are that after examining a suspected COVID-19 case, the CT equipment needs to be disinfected immediately. The terms used are \"disinfect the imaging equipment immediately after the examination.\" The procedures are referred to as sterilization or disinfection processes for fever-CTs or noncontaminated CTs. \n\nThe answer should mention that the recommended procedure is to disinfect the CT scanner immediately after the examination. The context doesn't specify the exact steps (like which disinfectants to use), but it emphasizes the timing\u2014right after the exam. So the answer should focus on the immediate disinfection post-examination for suspected cases.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a suspected COVID-19 case is to **immediately disinfect the imaging equipment following the examination**. The context emphasizes that sterilization or disinfection processes should be performed promptly after the procedure to ensure safety, particularly for \"fever-CTs\" or noncontaminated CT equipment. Specific steps (e.g., disinfectants or protocols) are not detailed in the provided passages, but the critical action is the immediate post-examination disinfection.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}